Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

32.60
Delayed Data
As of Apr 28
 -0.60 / -1.81%
Today’s Change
14.14
Today|||52-Week Range
33.65
+29.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues12.0M122.0M144.4M215.0M
 
 
 
 
 
Cost of Goods Sold362.0K4.8M7.5M9.6M
 
 
 
 
 
Depreciation And Amortization742.0K928.0K921.0K2.4M
 
 
 
 
 
 
Operating ExpensesGross Income10.9M116.3M136.0M203.0M
 
 
 
 
 
General Expenses72.8M92.1M118.3M148.8M
 
 
 
 
 
Research And Development17.2M19.6M29.1M42.8M
 
 
 
 
 
Total Operating Expenses73.9M97.8M126.8M160.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-61.9M24.2M17.7M54.2M
 
 
 
 
 
Extraordinary Credit0.002.8M193.0K448.0K
 
 
 
 
Extraordinary Charge-22.9M-2.6M-2.3M-671.0K
 
 
 
 
 
Interest Expense On Debt7.8M5.0M1.2M5.1M
 
 
 
 
 
Other Expenses101.0K39.0K38.0K-15.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-92.3M19.9M15.0M50.4M
 
 
 
 
 
Income Taxes0.000.00-956.0K-40.9M
 
 
 
Net Income-92.3M19.9M14.0M91.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.8M42.3M47.5M49.5M
 
 
 
 
 
Shares To Calculate EPS Diluted31.8M50.6M51.2M51.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.90$0.32$0.28$1.76
 
 
 
 
 
EPS Diluted-$2.90$0.32$0.28$1.76